Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cited by (1,003)

Items 101–200 of 1,003

1. Proteomics technologies for cancer liquid biopsies
   Zhiyong Ding, Nan Wang, Ning Ji, Zhe‐Sheng Chen · 2022 · Molecular Cancer
2. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
   Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li · 2022 · EBioMedicine
3. Circulating tumor DNA as an early cancer detection tool
   Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, Russell C. Rockne, Janet V. Mokhnatkin, Muhammed Murtaza, Stacy W. Gray, Laura H. Goetz, Ajay Goel, Nicholas J. Schork et al. · 2019 · Pharmacology & Therapeutics
4. Non-Invasive Biomarkers for Early Detection of Breast Cancer
   Jiawei Li, Xin Guan, Zhimin Fan, Lai‐Ming Ching, Yan Li, Xiaojia Wang, Wen‐Ming Cao, Dong‐Xu Liu · 2020 · Cancers
5. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
   Yuxuan Wang, Lu Li, Christopher Blair Douville, Joshua David Cohen, Ting‐Tai Yen, Isaac Kinde, Karin Sundfelt, Susanne K. Kjær, Ralph H. Hruban, Ie‐Ming Shih et al. · 2018 · Science Translational Medicine
6. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
   Stamatia Rontogianni, Eleni Synadaki, Bohui Li, Marte C. Liefaard, Esther H. Lips, Jelle Wesseling, Wei Wu, Maarten A. F. Altelaar · 2019 · Communications Biology
7. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma
   Lin Huang, Lin Wang, Xiaomeng Hu, Sen Chen, Peng Tao, Haiyang Su, Jing Yang, Wei Lin Xu, Vadanasundari Vedarethinam, Shu‐Pao Wu et al. · 2020 · Nature Communications
8. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
   Peiyong Jiang, Kun Sun, Yu K. Tong, Suk Hang Cheng, Timothy H.T. Cheng, Macy M. S. Heung, John Wong, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan, K. C. Allen Chan et al. · 2018 · Proceedings of the National Academy of Sciences
9. Inferring gene expression from cell-free DNA fragmentation profiles
   Mohammad Shahrokh Esfahani, Emily G. Hamilton, Mahya Mehrmohamadi, Barzin Y. Nabet, Stefan Alig, Daniel A. King, Chloé Beate Steen, Charles W. Macaulay, André Schultz, Monica C. Nesselbush et al. · 2022 · Nature Biotechnology
10. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
    Stephen Lam Chan, Hui‐Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B. El‐Serag, Jeong Min Lee, Myron Schwartz, Richard S. Finn, Jinsil Seong, Xin Wei Wang et al. · 2025 · The Lancet
11. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
    Artemiy Silantyev, Luca Falzone, Massimo Libra, Olga Ivanovna Gurina, K. Sh. Kardashova, Τaxiarchis Κonstantinos Νikolouzakis, Alexander E. Nosyrev, Chris W. Sutton, Panayiotis D. Mitsias, Aristidis Michael Tsatsakis · 2019 · Cells
12. Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer
    Rahul Bhome, Filippo Del Vecchio, Gui-Han Lee, Marc D. Bullock, John M. Primrose, Emre Sayan, Alex H. Mirnezami · 2018 · Cancer Letters
13. Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
    Yuxuan Wang, Lu Li, Joshua David Cohen, Isaac Kinde, Janine Ptak, Maria Popoli, Joy Schaefer, Natalie Silliman, Lisa Dobbyn, Jeanne Tie et al. · 2019 · JAMA Oncology
14. Circulating tumor DNA: current challenges for clinical utility
    Donna K. Dang, Ben Ho Park · 2022 · Journal of Clinical Investigation
15. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
    Qian Wang, Zeynep Hulya Gumus, Cristina Colarossi, Lorenzo Memeo, Xintong Wang, Chung Yin Kong, Paolo Boffetta · 2022 · Journal of Thoracic Oncology
16. Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA
    Lee Serpas, Rebecca W.Y. Chan, Peiyong Jiang, Meng Ni, Kun Sun, Ali Rashidfarrokhi, Chetna Soni, Vanja Sisirak, Wing‐Shan Lee, Suk Hang Cheng et al. · 2018 · Proceedings of the National Academy of Sciences
17. Cholangiocarcinoma — novel biological insights and therapeutic strategies
    Sumera Irie Ilyas, Silvia Affò, Lipika Goyal, Ángela Lamarca, Gonzalo Sapisochín, Ju Dong Yang, Gregory James Gores · 2023 · Nature Reviews Clinical Oncology
18. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis
    Guangxi Wang, Mantang Qiu, Xudong Xing, Juntuo Zhou, Hantao Yao, Mingru Li, Rong H. Yin, Yan Hou, Yang Li, Shuli Pan et al. · 2022 · Science Translational Medicine
19. Current AI technologies in cancer diagnostics and treatment
    Ashutosh Tiwari, Soumya Nandan Mishra, Tsung‐Rong Kuo · 2025 · Molecular Cancer
20. Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
    John B. Kisiel, Brian A. Dukek, Reddappa V.S.R. Kanipakam, Hassan M. Ghoz, Tracy C. Yab, Calise K. Berger, William R. Taylor, Patrick H. Foote, Nasra H. Giama, Kristeen Onyirioha et al. · 2018 · Hepatology
21. Application of Next Generation Sequencing in Laboratory Medicine
    Yiming Zhong, Feng Xu, Jinhua Wu, Jeffrey A. Schubert, Marilyn M. Li · 2020 · Annals of Laboratory Medicine
22. Colorimetric sensing for translational applications: from colorants to mechanisms
    Zhicheng Jin, Wonjun Yim, Maurice Retout, Emily Housel, Wenbin Zhong, Jiajing Zhou, Michael S. Strano, Jesse V. Jokerst · 2024 · Chemical Society Reviews
23. Early Detection of Ovarian Cancer
    Kevin Meyer Elias, Jing Guo, Robert C. Bast · 2018 · Hematology/Oncology Clinics of North America
24. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning
    Naixin Liang, Bingsi Li, Ziqi Jia, Chenyang Wang, Pancheng Wu, Tao Zheng, Yanyu Wang, Fujun Qiu, Yijun Wu, Jing Su et al. · 2021 · Nature Biomedical Engineering
25. Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
    Vincent P. Groot, Stacy L. Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis, Ding Ding, Lisa M. Haley, Jun Yu, Richard Andrew Burkhart, Alina Hasanain et al. · 2019 · Clinical Cancer Research
26. Synthetic biomarkers: a twenty-first century path to early cancer detection
    Gabriel A. Kwong, Sharmistha Ghosh, Lena Gamboa, Christos Patriotis, Sudhir Srivastava, Sangeeta N. Bhatia · 2021 · Nature reviews. Cancer
27. Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection
    Fahrmann, Johannes F., Schmidt, C. Max, Mao, Xiangying, Irajizad, Ehsan, Loftus, Maureen, Zhang, Jinming, Patel, Nikul, Vykoukal, Jody, Dennison, Jennifer B., Long, James P. et al. · 2021 · Gastroenterology
28. A mathematical model of ctDNA shedding predicts tumor detection size
    Stefano Avanzini, David Matthew Kurtz, Jacob J. Chabon, Everett James Moding, Sharon Seiko Hori, Sanjiv Sam Gambhir, Ash A. Alizadeh, Maximilian Diehn, Johannes G. Reiter · 2020 · Science Advances
29. Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring
    Ivana Martins, Ilda Patrícia Ribeiro, Joana Jorge, Ana Cristina Gonçalves, Ana Bela Sarmento‐Ribeiro, Joana Barbosa Melo, Isabel M. Carreira · 2021 · Genes
30. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development
    Jawara Allen, Cynthia L. Sears · 2019 · Genome Medicine
31. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA
    Nathan Wan, David E. Weinberg, Tzu‐Yu Liu, Katherine E. Niehaus, Daniel Delubac, Ajay Kannan, Brandon White, Eric A. Ariazi, Mitch Bailey, Marvin Bertin et al. · 2019 · BMC Cancer
32. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Peneder, Peter, Stütz, Adrian M., Surdez, Didier, Krumbholz, Manuela, Semper, Sabine, Chicard, Mathieu, Sheffield, Nathan C., Pierron, Gaelle, Lapouble, Eve, Tötzl, Marcus et al. · 2021 · Nature Communications
33. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
    Elena M. Stoffel, Shannon E. McKernin, Randall E. Brand, Marcia Irene Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M. Petersen, Diane M. Simeone, Matthew B.B. Yurgelun et al. · 2018 · Journal of Clinical Oncology
34. Cancer biomarker discovery and translation: proteomics and beyond
    Ventzislava A. Hristova, Daniel W. Chan · 2018 · Expert Review of Proteomics
35. Applications of liquid biopsies for cancer
    Austin K. Mattox, Chetan Bettegowda, Shibin Zhou, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein · 2019 · Science Translational Medicine
36. Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
    Nader El-Sayes, Alyssa Vito, Karen Louise Mossman · 2021 · Cancers
37. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
    Maryam A Aleissa, Lane Lerner, Eihab Abdelfatah, Nakul Shankar, Joseph K. Canner, Nesrin M. Hasan, Vesal Yaghoobi, Barry Huang, Zachary J. Kerner, Felipe Takaesu et al. · 2019 · Clinical Epigenetics
38. ctDNA monitoring using patient-specific sequencing and integration of variant reads
    Jonathan C. M. Wan, Katrin Heider, Davina Gillian Gale, Suzanne Murphy, Eyal Fisher, Florent C. Mouliere, Andrea Ruiz-Valdepeñas, Ángela Santonja, James Morris, Dineika Chandrananda et al. · 2020 · Science Translational Medicine
39. Tumor-educated platelets
    Sjors G. J. G. In ‘t Veld, Thomas Würdinger · 2019 · Blood
40. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I, Chen, Kevin, Usmani, Abul, Chua, Chanelle, Harris, Peter K., Binkley, Michael S., Azad, Tej D., Dudley, Jonathan C., Chaudhuri, Aadel A. · 2019 · Molecular Diagnosis & Therapy
41. Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
    Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Lucía Robado de Lope, Víctor González‐Rumayor, Atocha Romero, Mariano Provencio · 2022 · Frontiers in Oncology
42. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Du-Bois Asante, Leslie Calapre, Mel R. Ziman, Tarek M. Meniawy, Elin Solomonovna Gray · 2019 · Cancer Letters
43. Lipidomic profiling of human serum enables detection of pancreatic cancer
    Denise Wolrab, Robert Jirásko, Eva Cífková, Marcus Höring, Mei Ding, Michaela Chocholoušková, Ondřej Peterka, Jakub Idkowiak, Tereza Hrnčiarová, Ladislav Kuchař et al. · 2022 · Nature Communications
44. Electrochemical Impedance Spectroscopy Based Biosensors: Mechanistic Principles, Analytical Examples and Challenges towards Commercialization for Assays of Protein Cancer Biomarkers
    Tomáš Bertók, Lenka Lorencová, Erika Chocholova, Eduard Jáné, Alica Vikartovská, Peter Kasák, Jan Tkáč · 2018 · ChemElectroChem
45. Artificial intelligence in oncology: path to implementation
    Chua, Isaac S., Gaziel‐Yablowitz, Michal, Korach, Zfania T., Kehl, Kenneth L., Levitan, Nathan A., Arriaga, Yull E., Jackson, Gretchen P., Bates, David W., Hassett, Michael · 2021 · Cancer Medicine
46. Biomarkers for Hepatobiliary Cancers
    Jean‐Charles Nault, Augusto Villanueva · 2020 · Hepatology
47. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals
    Amanda L. Blackford, Marcia Irene Canto, Mohamad H. Dbouk, Ralph H. Hruban, Bryson W. Katona, Amitabh Chak, Randall E. Brand, Sapna Syngal, James J. Farrell, Fay Kastrinos et al. · 2024 · JAMA Oncology
48. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
    W.K. Lam, Peiyong Jiang, K.C. Allen Chan, Suk Hang Cheng, Haiqiang Zhang, Wenlei Peng, O. Y. Olivia Tse, Yu K. Tong, Wanxia Gai, Benny Chung-Ying Zee et al. · 2018 · Proceedings of the National Academy of Sciences
49. Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
    C. Qu, Yu-Ting Wang, Pei-pei Wang, Kun-Tian Chen, Min-Jie Wang, Hongmei Zeng, Jianquan Lu, Q. Song, B. Diplas, D. Tan et al. · 2019 · Proceedings of the National Academy of Sciences of the United States of America
50. Liquid biopsies
    Evi S. Lianidou, Klaus Pantel · 2018 · Genes Chromosomes and Cancer
51. Novel Approaches to Screening for Breast Cancer
    Ritse M. Mann, Regina J. Hooley, Richard G. Barr, Linda P. Moy · 2020 · Radiology
52. Debugging Nano–Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies
    Morteza Mahmoudi · 2018 · Trends in biotechnology
53. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
    Austin K. Mattox, Christopher Blair Douville, Yuxuan Wang, Maria Popoli, Janine Ptak, Natalie Silliman, Lisa Dobbyn, Joy Schaefer, Steve Lu, Alexander H. Pearlman et al. · 2023 · Cancer Discovery
54. Plasmonic Alloys Reveal a Distinct Metabolic Phenotype of Early Gastric Cancer
    Haiyang Su, Xinxing Li, Lin Huang, Jing Cao, M. Zhang, Vadanasundari Vedarethinam, Wen J. Di, Zhiqian Hu, Kun Qian · 2021 · Advanced Materials
55. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    Juliane Marie Liberto, Sheng-Yin Chen, Ie‐Ming Shih, Tza‐Huei Wang, Tian‐Li Wang, Thomas R. Pisanic · 2022 · Cancers
56. Barcoded point-of-care bioassays
    Mingzhu Yang, Yong Liu, Xingyu Jiang · 2018 · Chemical Society Reviews
57. Potential clinical utility of liquid biopsies in ovarian cancer
    Jie Wei Zhu, Parsa Charkhchi, Mohammad Reza Akbari · 2022 · Molecular Cancer
58. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
    Kenner, Barbara, Chari, Suresh T., Kelsen, David, Klimstra, David S., Pandol, Stephen J., Rosenthal, Michael, Rustgi, Anil K., Taylor, James A., Yala, Adam, Abul-Husn, Noura et al. · 2021 · Pancreas
59. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status
    Georgios Gemenetzis, Vincent P. Groot, Jun Yu, Ding Ding, Jonathan A. Teinor, Ammar A. Javed, Laura DeLong Wood, Richard Andrew Burkhart, John L. Cameron, Martin A. Makary et al. · 2018 · Annals of Surgery
60. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
    Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Rui Manuel Reis, Letícia Ferro Leal · 2023 · International Journal of Molecular Sciences
61. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis
    Jicheng Wu, Shen Hu, Lihong Zhang, Jinxia Xin, Chongran Sun, Liquan Wang, Kefeng Ding, Ben Wang · 2020 · Theranostics
62. Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test
    Juan Pablo Hinestrosa, Razelle Kurzrock, Jean M. Lewis, Nicholas J. Schork, Gregor Schroeder, Ashish M. Kamat, Andrew M. Lowy, Ramez Nassef Eskander, Orlando Perrera, David J. Searson et al. · 2022 · Communications Medicine
63. Circulating cell-free DNA for cancer early detection
    Qiang Gao, Qiang Zeng, Zhijie Wang, Chengcheng Li, Yu Xu, Peng Cui, Zhu Xin, Huafei Lu, Guoqiang Wang, Shangli Cai et al. · 2022 · The Innovation
64. Multiplexed analysis of EV reveals specific biomarker composition with diagnostic impact
    Joshua D. Spitzberg, Scott W. Ferguson, Katherine S. Yang, Hannah M. Peterson, Jonathan Carlson, Ralph Weissleder · 2023 · Nature Communications
65. The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion
    Zijian Hu, Honghong Chen, Yanzhu Long, Ping Li, Yueqing Gu · 2020 · Critical Reviews in Oncology/Hematology
66. DNA-framework-based multidimensional molecular classifiers for cancer diagnosis
    Fangfei Yin, Haipei Zhao, Shasha Lu, Juwen Shen, Min Li, Xiuhai Mao, Fan Li, Jiye Shi, Jiang Li, Baijun Dong et al. · 2023 · Nature Nanotechnology
67. Molecular mechanisms of the preventable causes of cancer in the United States
    Erica A. Golemis, Paul A. Scheet, Tim N. Beck, Eward M. Scolnick, David J. Hunter, Ernest T. Hawk, Nancy H. Hopkins · 2018 · Genes & Development
68. High-throughput proteomics and AI for cancer biomarker discovery
    Qi Xiao, Fangfei Zhang, Luang Xu, Liang Yue, Oi Lian Kon, Yi Zhu, Tiannan Guo · 2021 · Advanced Drug Delivery Reviews
69. A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
    Indu Kohaar, György Petrovics, Shiv K. Srivastava · 2019 · International Journal of Molecular Sciences
70. FeOOH@Metal–Organic Framework Core–Satellite Nanocomposites for the Serum Metabolic Fingerprinting of Gynecological Cancers
    Congcong Pei, Chao Liu, You Wang, Dan Cheng, Rongxin Li, Weikang Shu, Chaoqi Zhang, Wenli Hu, Aihua Jin, Yannan Yang et al. · 2020 · Angewandte Chemie International Edition
71. Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test
    Earl A. Hubbell, Christina A. Clarke, Alexander M. Aravanis, Christine D. Berg · 2020 · Cancer Epidemiology Biomarkers & Prevention
72. The future of liquid biopsy
    Catherine Alix‐Panabières · 2020 · Nature
73. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
    Nicola Normanno, Andrès M.R. Cervantes, Fortunato Ciardiello, Antonella De Luca, Carmine Pinto · 2018 · Cancer Treatment Reviews
74. Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective
    Muhammad Sufyan, Zeeshan Shokat, Usman Ali Ashfaq · 2023 · Computers in Biology and Medicine
75. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
    Xiaolin Wu, Jiahui Li, Asmae Gassa, Denise Buchner, Hakan Alakus, Qiongzhu Dong, Ning Ren, Ming Liu, Margarete Odenthal, Dirk Ludger Stippel et al. · 2020 · International Journal of Biological Sciences
76. Molecular Diagnostics in Clinical Oncology
    Анна Петровна Соколенко, Евгений Наумович Имянитов · 2018 · Frontiers in Molecular Biosciences
77. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
    Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D’Amico, Giulia Viale, Dario Trapani, Bruno Achutti Duso, Giuseppe Curigliano · 2018 · Critical Reviews in Oncology/Hematology
78. Integrating Artificial and Human Intelligence: A Partnership for Responsible Innovation in Biomedical Engineering and Medicine
    Kevin Dzobo, Sampson Kofi Adotey, Nicholas Ekow Thomford, Witness Dzobo · 2019 · OMICS A Journal of Integrative Biology
79. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
    Edward Geeurickx, An Hendrix · 2019 · Molecular Aspects of Medicine
80. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
    Giovanna Rossi, Michail Ignatiadis · 2019 · Cancer Research
81. Detection and localization of early- and late-stage cancers using platelet RNA
    Sjors G. J. G. In ‘t Veld, Mohammad Arkani, Edward Post, Mafalda Antunes‐Ferreira, Silvia D’Ambrosi, Daan C.L. Vessies, Lisa Vermunt, Adrienne Vancura, Mirte Muller, Anna-Larissa Nadia Niemeijer et al. · 2022 · Cancer Cell
82. Liquid biopsy in the clinical management of hepatocellular carcinoma
    von Felden, Johann, Garcia-Lezana, Teresa, Schulze, Kornelius, Losic, Bojan, Villanueva, Augusto · 2020 · Gut
83. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
    Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Stéphanie Calfa, Cássio Murilo Trovo Hidalgo Filho, Tatiana Takahasi Komoto, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques · 2022 · International Journal of Molecular Sciences
84. Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance
    Greytak, Sarah R., Engel, Kelly B., Parpart-Li, Sonya, Murtaza, Muhammed, Bronkhorst, Abel J., Pertile, Mark D., Moore, Helen M. · 2020 · Clinical Cancer Research
85. Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
    Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, Ilaria Alborelli, Luca Quagliata, Charlotte K.Y. Ng, Salvatore Piscuoglio, Nicola Aceto · 2018 · Diagnostics
86. Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
    Young Kwang Chae, Michael S. Oh · 2018 · Journal of Thoracic Oncology
87. RNA sequencing and swarm intelligence–enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA
    Myron G. Best, Sjors G. J. G. In ‘t Veld, Nik Sol, Thomas D. Wurdinger · 2019 · Nature Protocols
88. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
    Sarah Østrup Jensen, Nadia Øgaard, Mai‐Britt W. Ørntoft, Mads Heilskov Rasmussen, Jesper B. Bramsen, Helle Kristensen, Peter Mouritzen, Mogens Rørbæk Madsen, Anders Husted Madsen, Kåre Andersson Gotschalck et al. · 2019 · Clinical Epigenetics
89. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
    Adam J. Widman, Minita J. Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard, Srinivas Rajagopalan, Anushri Arora, Aditya S. Deshpande, William F. Hooper et al. · 2024 · Nature Medicine
90. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
    Shelize Sadrudin Khakoo, Paul David Carter, Gina M. Brown, Nicola Valeri, Simona Picchia, Maria Antonietta Bali, Ridwan Shaikh, Thomas Jones, Ruwaida Begum, Isma Rana et al. · 2019 · Clinical Cancer Research
91. Ovarian cancer screening: Current status and future directions
    Zachary Nash, Usha Menon · 2020 · Best Practice & Research Clinical Obstetrics & Gynaecology
92. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
    Charles‐Hugo Marquette, Jacques Boutros, Jonathan Benzaquen, Marion Ferreira, Jean Pastré, Christophe M. Pison, B. Padovani, Faiza Bettayeb, Vincent Fallet, Nicolas Marie Guibert et al. · 2020 · The Lancet Respiratory Medicine
93. Liquid Biopsies, Novel Approaches and Future Directions
    Athanasios Armakolas, Maria Kotsari, John S. Koskinas · 2023 · Cancers
94. Universal cancer screening: revolutionary, rational, and realizable
    Ahlquist, David A. · 2018 · npj Precision Oncology
95. A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy
    Keisuke Asakura, Tsukasa Kadota, Juntaro Matsuzaki, Yukihiro Yoshida, Yusuke Yamamoto, Kazuo Nakagawa, Satoko Takizawa, Yoshiaki Aoki, Eiji Nakamura, Junichiro Miura et al. · 2020 · Communications Biology
96. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma
    Naga Chalasani, Tiruvidaimarudur S. Ramasubramanian, Abhik Bhattacharya, Marilyn C. Olson, David K. Edwards V, Lewis Rowland Roberts, John B. Kisiel, K. Rajender Reddy, Graham P. Lidgard, Scott C. Johnson et al. · 2020 · Clinical Gastroenterology and Hepatology
97. Bridging biological cfDNA features and machine learning approaches
    Tina Moser, Stefan Kühberger, Isaac Lazzeri, Georgios Vlachos, Ellen Heitzer · 2023 · Trends in Genetics
98. Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing
    Kun Sun, Peiyong Jiang, Ada I. C. Wong, Yvonne Kwun Yue Cheng, Suk Hang Cheng, Haiqiang Zhang, K.C. Allen Chan, Tak Yeung Leung, Rossa W. K. Chiu, Yuk Ming Dennis Lo · 2018 · Proceedings of the National Academy of Sciences
99. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
    Lydia Giannopoulou, Martha Zavridou, Sabine Kasimir‐Bauer, Evi S. Lianidou · 2018 · Translational research
100. Novel Approaches to Ovarian Cancer Screening
     Denise R. Nebgen, Karen H. Lu, Robert C. Bast · 2019 · Current Oncology Reports